When we will see a film at the Gaumont or buy a CD at Virgin,
we do not doubt that somewhere
2010-02-02 
When we will see a film at the Gaumont or buy a CD at Virgin, we do not doubt that somewhere in the floors of the Alliance building, or in the surrounding area to large companies like apartments are developing high-flying technologies , applied to the life science, that is to say we humans. So what Gaillard and Saint-Julien-en-Genevois are implanted in very big companies (Bayer Health Home and Pierre Fabre) in the technology park of Archamps a scientific hive activates finding drugs, treatments, or designs of equipment "France offers the best conditions in Switzerland for the establishment of new companies" serious diseases such as cancer and neurodegenerative diseases are the target start-ups based in the French Genevois, specifically the "southern Porte de Geneve". Some of these companies are bi-locals, with headquarters in Switzerland, or simply choose to settle in France, because it would become Interestingly government grants and tax credits, as well as the status of young innovative company, had an effect "France now offers the best conditions in Switzerland for the establishment of new businesses," said Herve Kergrohen, Biodata show organiser. Haute-Savoie intends to pull out of the game for Roland Pascal, chairman of the board of the Archamps Technopole, "we must affirm our vocation for biotechnology. The bow is a biotechnology location main homes in Europe and Haute savoie must take his share in biotechnology.
We try to be positive the Franco-Swiss border complexity in an area with de-industrialization, you have to play the logic of science park, which joins that of competitiveness poles. "These goals include four chapters research (Biopark with a technical station installed 2M6), training (an institute of life sciences is planned), start-ups (a nursery to be built), events (Biodata and soon other events) new companies have recently installed, and other requests come, we must create the conditions for reception of biotechnology that come from a between biology and manages a set of new techniques from other disciplines such as microbiology (science that studies microorganisms), biochemistry, biophysics, genetics, molecular biology, computer science in the health sector, the discovery of new treatments is more additional
Use biotechnology to investigate the causes of diseases, design, test and produce specific drugs. This implies a very important research effort to understand the functioning of organizations and develop drugs capable of acting on their perturbations "Biotech" includes a enterprise specializing in biotechnology. Archamps welcomes the pharmaceutical company Addex (pictured), Cerma company that develops devices for the treatment of tumors, the laboratory Cell made (primary cells) Genomic company (robots for analytical laboratories), Maat Knowledge (software applications), Animascope (in vivo imaging) BioXtal (protein crystallography) Two new Dermadis (treatment of a serious skin disease) and GeNeuro (binds with Biomerieux)
PONCET Catherine